15. Congress of the European College for the Study of Vulval Disease

Registration now open

Greetings

Dear colleagues and friends,

It is our great pleasure to welcome you to the 15. Congress of the European College for the Study of Vulval Disease in Hamburg, Germany – for the first time in the history of our Society!

We are happy to offer you a live congress in the beautiful city of Hamburg and are looking forward to welcoming participants from all over Europe, but also from Australia, Canada and around the world. Among invited guests, we have representatives from the International Society for the Study of Vulvovaginal Disease and the British Society for the Study of Vulval Disease, as well.  

The program follows the traditional set up, including educational plenary lectures, some shorter hot-topic-lectures, a few interesting interactive sessions, as well as presentations of abstracts on the latest scientific works carried out by our current and future members. We also offer pre-congress work-shops on biopsy taking, ablative and non-ablative laser treatment and reconstruction after mutilation and cancer surgery!  

The social program includes a visit to the famous Miniatur – Wonderland, a speakers dinner at the beautiful Restaurant “Am Kai” located at the harbor as well as a the congress dinner at “Café Schöne Aussichten”, located in the middle of Hamburg, close to the congress venue. You will have an excellent possibility to mingle with your old friends and make new acquaintances in this beautiful setup.

Now that the congress is getting closer and arrangements begin to be finalized, we really hope for a successful congress with you!

Please do not miss the opportunity to join us!

Prof. Dr. med. Linn Woelber, president ECSVD

Dr. med. Anna Jaeger, secretary ECSVD congress

Location

Philosophenturm Hamburg, Hamburg University, Germany

Phil-Turm, Von-Melle-Park 6
20146 Hamburg, Germany

SCIENTIFIC PROGRAM

Scientific Program download

Thursday, Sept 18th

01.00 – 03.00 pm
Pre-congress hands-on workshop: Biopsy taking, ablative and non-ablative Lasertreatment

Dr. med Christopher Koßagk Berlin (Germany), Dr. Alexander Luyten Kiel (Germany)

(limited availability)

03.00 – 05.00 pm
Pre-congress surgical workshop: Vulvar reconstruction

PD Dr. Dan mon O’Dey, Heidelberg (Germany)

(limited availability)

5.30 pm
Social event

Miniaturwunderland Hamburg
Kehrwieder 2/Block D, 20457, Hamburg, Germany

(limited availability)

7.30 pm
Speakers dinner

am kai | restaurant. seafood. drinks. elbblick
Große Elbstraße 145c, 22767 Hamburg, Germany

Friday, Sept 19th

08.00 – 09.00 am
Registration
08:45 – 09:00 am
Presidential Welcome

Linn Woelber, Hamburg (Germany)

09.00 – 10.00 am
Vulva the basics

Chair: Waltraud Anemüller, Kiel (Germany), Manon van Seters, Worcester (Great Britain)

Vulvar anatomy in different ages –
from childhood to postmenopausal age

Dr. Micheline Moyal-Barracco, Paris (France)

Clinical examination of the vulva

Waltraud Anemüller, Kiel (Germany)

Clinical information relevant for the pathologist, histologic characteristics of vulvar and vestibular tissue

Jim Scurry, Newcastle (Australia)

Differential diagnoses of benign lesions Quiz

Prof. Dr. Christina Damsted Petersen, Kopenhagen (Denmark)

10.00 – 10.30 am
COFFEE BREAK
10.30 – 12.30 am
Common vulval dermatoses

Chair: Prof. Dr. Pia Halonen, Helsinki (Finland) , Dr. med. Gudula Kirtschig, Frauenfeld (Germany)

Lichen sclerosus: clinical characteristics, course of disease and topical treatment

Prof. Dr. Pia Halonen, Helsinki (Finland)

Lichen planus: clinical characteristics, course of disease and topical treatment

Prof. Dr. Fiona Lewis, London (Great Britain)

A pathologist`s view

Prof. Sigrid Regauer, Graz (Austria)

Alternative topical options (Laser/PDT/Plasma)

Prof. Dr. Clemens Tempfer, Herne (Germany)

Future treatment options for dermatoses
with vulvar involvement

Dr. Christine Braegelmann, Bonn (Germany)

Differential diagnoses of vulvar lesions Quiz

Christina Damsted-Petersen, Copenhagen (Denmark)

12.30 – 01.30 pm
LUNCH BREAK
12.45 – 01.15 pm
Lunchsymposium 1
Laser treatment for vulvar disease

General mechanisms, current clinical data, current histopathological data

PD Dr. Anna Jaeger, Hamburg (Germany)

PD Dr. Katharina Herberger, Hamburg (Germany)

1.30 – 2.30 pm
Vulva pain

Chair: Päivi Tommola, Helsinki (Finland), N.N.

Provoked Vulvodynia – up to date treatment

Prof. Dr. Christina Damsted Petersen, Kopenhagen (Denmark)

New therapeutic approaches incl. core outcome set
for future research

Ulrika Heddini, Stockholm (Sweden)

Discussion/Relevant abstracts presentation

2.30 – 3.30 pm
Female genitale mutilation (FGM)

Chair: Nina Bohm-Starke, Danderyd (Switzerland), Sophie Berville, Paris (France)

Anatomy of the clitoris, types (in adults and minors), complications and management

Dr. med Jasmine Abdulcadir, Geneva (Switzerland)

MAJORIE RIDLEY SPEECH:
Surgical aspects, reconstruction

PD Dr. Dan mon O’Dey, Heidelberg (Germany)

Discussion/Relevant abstracts presentation

3.30 – 4.00 pm
COFFEE BREAK
4.00 – 5.00 pm
Vulva and the vaginal microbiome

Chair: Prof. Dr. Hans Verstraelen, Gent (Belgium),  Prof. Dr. Pedro Vieira-Baptista, Porto (Portugal)

Normal vaginal microbiome

Prof. Dr. Hans Verstraelen, Gent (Belgium)

Dysbioses of vaginal microbiome

Prof. Dr. Pedro Vieira-Baptista, Porto (Portugal)

Wet Mount Microscopy

Dr. med. Päivi Tommola, Helsinki (Finland)

Prebiotics, probiotics, postbiotics

PD Dr. Anna Jaeger, Hamburg (Germany)

Discussion/Relevant abstracts presentation

5.00 – 6.00 pm
Infectious diseases

Chair: Werner Mendling, Wuppertal (Germany), Sophie Berville, Paris (France)

Candidosis / aerobic colpitis

PhD Svitrigaile Grincevičienė, Lithuania (Slowakia)

Update STDs

Johan Chanal, Paris (France)

Indication and performance of molecular tests for suspected vulvovaginal infections

Prof. Dr. Werner Mendling, Wuppertal (Germany)

Update Hidradenitis suppurativa

7.30 pm
ECSVD night

Café Schöne Aussichten
Gorch-Fock-Wall 4, 20354 Hamburg, Germany
(limited availability)

Saturday, Sept 20th

09.00-11.00 am
pre-invasive diseases

Chair: Dr. Manon van Seters, Worcester (Great Britain), Prof. Dr. Christian Dannecker, Augsburg (Germany)

VIN – subtypes and prognosis

Prof. Dr. Mario Preti, Torino (Italy)

Management/treatment options for VIN

Dr. med. Niccolò Gallio, Torino (Italy)

Prognostic biomarkers in VIN (Methylation)

Dr. Maaike Bleeker, Amsterdam (Netherlands)

Prophylaxis of vulvar precancerous conditions, vaccination

Univ.-Prof. Dr. Elmar A. Joura, Vienna (Austria)

Anal lesions – screening, diagnosis and treatment

Andreia Albuquerque, Porto (Portugal)

Paget disease

Prof. Dr. Monika Hampl, Köln (Germany)

Discussion/Relevant abstracts presentation

Mareike Alter, Minden (Germany)

11.00-11.30 am
ISSVD address: How can we move forward with vulvar diseases

Debbie Roepe, Waxhaw (USA)

12.00-1.00 pm
Lunch Symposium II Melanoma and MIS
SPONSORED

Dr. Peter Mohr, Buxtehude (Germany)

12.00 – 1.00 pm
LUNCH BREAK
11.30 – 12.15 am
Guided Postersession

Epidemiology and risk factors

Prof. Dr. Christian Dannecker, Augsburg (Germany)

Tumorbiology, recent developments

Niclas Blessin, Kiel (Germany)

Surgery of the primary tumor

Prof. Dr. Sven Mahner, Munich (Germany)

Treatment of the lymphatics

Dr. Maiike Oonk, Groningen (Netherlands)

Update Melanoma of the vulva/vagina

N.N.

Radiooncology incl. management of side effects

Prof. Dr. Cordula Petersen, Hamburg (Germany)

Systemic therapy gynecologic squamous cell cancers – developments

Prof. Dr. Linn Wölber, Hamburg (Germany)

Discussion/Relevant abstracts presentation

1.00 – 3.15 pm
Invasive disease

Chair: Prof. Dr. Linn Wölber, Hamburg (Germany), Prof. Dr. Monika Hampl, Köln (Germany)

3.30 – 4.30 pm
Awards of the best abstracts
ECSVD BUSINESS MEETING AND CLOSING REMARKS

Dr. Manon van Seters, Worcester (Great Britain)
Prof. Dr. Linn Wölber, Hamburg (Germany)
Prof. Dr. Fiona Lewis, London (Great Britain)

Scientific Program download

Call for abstracts

You can submit your abstract via mail to contact@ecsvd.eu. The best abstracts will be selected for oral presentation within scientific session. The best 5 abstracts will be awarded. Don’t miss the opportunity to present your research at an internationally renowned event!
Abstract submission deadline ends 30st of May 2025

Abstract submitters can participate in the conference for the Early Bird fee.

Important notes on abstracts

Abstract Topics

For review purposes, abstracts are classified according to the following list. Select only 1 topic on our submission form.

  • Vulva – the basics
  • Vulval dermatoses
  • Laser treatment for vulval disease
  • Vulva Pain
  • Female genital mutilation (FGM)
  • Vulva and the vaginal Microbiome
  • Infectious disease
  • Pre-invasive disease (vulva, vagina, cervix)
  • Invasive disease (vulva, vagina, cervix)
Abstract Editing Instructions
  • Abstracts must be submitted via mail to contact@ecsvd.eu
  • Your abstract should not exceed a total of 3,500 characters all sections included: Background/Objectives, Methods, Results, and Conclusion
  • The title should not be written in upper case (capitals), keep it as short as possible clearly indicating the nature of the investigation
  • All authors (main author and co-authors) should be listed with their last names (family names) and their first name(s). The published version will only mention the initial(s) of the first name(s).ONE author must be identified as the PRESENTER; the presenter commits to registering as a delegate (except if she/he is an invited speaker), to attend the congress and present the abstract
  • Please indicate professional addresses of all authors: Name of hospital, unit or laboratory, city and country in lower case. No other indications are to be given. Different affiliations will be automatically numbered
  • Only standard abbreviations may be used without definition. Data must be given in units widely used in literature
  • Only essential references should be included and put in brackets at the end of the abstract: Numbers in the text may refer to them
  • Drugs must be identified by their generic names and no company names should be mentioned in the title of the abstract

List of Speakers

Jasmine Abdulcadir

Hôpitaux Universitaires de Genève
Geneva (Switzerland)

MD PhD Andreia Albuquerque

Portuguese Oncology Institute of Porto
Porto (Portugal)

Dr. med. Waltraud Anemueller

Klinik für Dermatologie, UKSH- Campus Lübeck
Lübeck (Germany)

Dr. Sophie Berville

Paris (France)

Dr. Maaike Bleeker

Amsterdam UMC, afdeling pathologie/department of pathology
Amsterdam (Netherlands)

Prof. Dr. Nina Bohm-Starke

Kvinnokliniken
Danderyds sjukhus (Sweden)

Dr. Christine Braegelmann

Klinik und Poliklinik für Dermatologie und Allergologie,
UKB Universitätsklinikum Bonn
Bonn (Germany)

Prof. Dr. Eike-C. Burandt

Universitätsklinikum Hamburg-Eppendorf
Institut für Pathologie

Hamburg (Germany)

Prof. Dr. Christina Damsted Petersen

Klinik for kvindesygdomme og seksuel sundhed
Kopenhagen (Denmark)

Prof. Dr. Christian Dannecker

Universitätsklinikum Augsburg
Augsburg (Germany)

Dr. med. Niccolò Gallio

Department of Surgical Sciences
University of Torino
Torino (Italy)

PhD Svitrigaile Grincevičienė

Vilnius University
Vilnius (Lithuania)

Prof. Dr. Pia Halonen

Helsinki University
Central Hospital Department of Obstetrics and Gynaecology
Helsinki (Finland)

Prof. Dr. Monika Hampl

St. Elisabeth-Krankenhaus Köln-Hohenlind
Cologne (Germany)

Dr. Ulrika Heddini

lVO Kvinnosjukvård och förlossning
Stockholm (Sweden)

PD Dr. Anna Jaeger

Universitätsklinikum Hamburg-Eppendorf
Hamburg (Germany)

Univ.-Prof. Dr. Elmar A. Joura

Medizinische Universität Wien
Department of Obstetrics and Gynecology
(Division of General Gynecology and Gynecologic Oncology)
Wien (Austria)

Dr. med. Gudula Kirtschig

Medbase Frauenfeld
Frauenfeld (Switzerland)

Dr. med. Christopher Koßagk

Gynäkologisches Versorgungszentrum Kreuzberg MVZ / Zweigstelle Köpenick
Berlin (Germany)

Prof. Dr. Fiona Lewis

St John’s Institute of Dermatology
London (Great Britain)

Dr. Alexander Luyten

a&p MVZ GmbH
Kiel (Germany)

Prof. Dr. Sven Mahner

Klinik und Poliklinik für Frauenheilkunde und Geburtshilfe Klinikum Großhadern
Munich (Germany)

Prof. Dr. Werner Mendling

Landesfrauenklinik Helios
Universitätsklinikum Wuppertal
Wuppertal (Germany)

Dr. Peter Mohr

Elbe Kliniken Stade
Dermatologisches Zentrum Buxtehude
Buxtehude (Germany)

Dr. Micheline Moyal-Barracco

Cabinet médical docteur Moyal-Barracco
Paris (France)

PD Dr. Dan mon O’Dey

SALUTEM Praxisklinik
Heidelberg (Germany)

Dr. Maiike Oonk

Universitair Medisch Centrum Groningen
Groningen (Netherlands)

Prof. Dr. Cordula Petersen

Universitätsklinikum Hamburg-Eppendorf
Hamburg (Germany)

Prof. Dr. Mario Preti

University of Turin Dipartimento di Scienze Chirurgiche
Torino (Italy)

Prof. Sigrid Regauer

Diagnostik- und Wissenschaftsinstitut für Pathologie Medizinische Universität Graz
Graz (Austria)

Debbie Roepe

International Society For the Study of Vulvovaginal Disease
Waxhaw (USA)

Jim Scurry

The University of Newcastle Australia
Newcastle (Australia)

Prof. Dr. Clemens Tempfer

Universitäts-Frauenklinik der Ruhr-Universität Bochum Marien Hospital Herne
Herne (Germany)

Dr. med. Päivi Tommola

HUS Helsinki University Hospital
Helsinki (Finland)

Dr. Manon van Seters

Worcestershire Acute Hospital
Worcester (Great Britain)

Prof. Dr. Hans Verstraelen

Department of Obstetrics & Gynaecology
Ghent University Hospital 0P4
Gent (Belgium)

Prof. Dr. Pedro Vieira-Baptista

Hospital Lusíadas Porto
Porto (Portugal)

Prof. Dr. Linn Woelber

Universitätsklinikum Hamburg-Eppendorf
Hamburg (Germany)

Meet the council

get details by clicking on the Image

President

Linn Woelber

Germany

Past president

Päivi Tommola

Finland

Past past president

Elmar A. Joura

Austria

President elect

Fiona Lewis

UK

Secretary

Manon van Seters

Netherlands/UK

Treasurer

Micheline Moyal-Barracco

France

Treasurer

Sophie Berville

France

Council member

Ulrika Heddini

Sweden

Council member

Hans Verstraelen

Belgium

Council member

Christina Damsted-Petersen

Denmark

Council member

Jasmine Abdulcadir

Switzerland

Council member

Pia Halonen

Finland

Get more information about the ECSVD Membership

go to ecsvd.eu

Festive Evening

FRIDAY SEPTEMBER 19th

SCHEDULE

7:00
Meet at the Bus

9:00
Dinner

11:30
Transfer to Hotel

Festive Evening

Lorem ipsum dolor sit amet, consectetur adipiscing elit. Ut elit tellus, luctus nec ullamcorper mattis, pulvinar dapibus leo. Lorem ipsum dolor sit amet, consectetur adipiscing elit. Ut elit tellus, luctus nec ullamcorper mattis, pulvinar dapibus leo. Lorem ipsum dolor sit amet, consectetur adipiscing elit. Ut elit tellus, luctus nec ullamcorper mattis, pulvinar dapibus leo.Lorem ipsum dolor sit amet, consectetur adipiscing elit. Ut elit tellus, luctus nec ullamcorper mattis, pulvinar dapibus leo.

BOOK NOW
Membership
Programme
About us

ECSVD 2025

Lorem ipsum dolor sit amet, consectetur adipiscing elit. Ut elit tellus, luctus nec ullamcorper mattis, pulvinar dapibus leo.Lorem ipsum dolor sit amet, consectetur adipiscing elit. Ut elit tellus, luctus nec ullamcorper mattis, pulvinar dapibus leo.

Lorem ipsum dolor sit amet, consectetur adipiscing elit. Ut elit tellus, luctus nec ullamcorper mattis, pulvinar dapibus leo.Lorem ipsum dolor sit amet, consectetur adipiscing elit. Ut elit tellus, luctus nec ullamcorper mattis, pulvinar dapibus leo. Lorem ipsum dolor sit amet, consectetur adipiscing elit. Ut elit tellus, luctus nec ullamcorper mattis, pulvinar dapibus leo.

Further sponsorship opportunities

Lorem ipsum dolor sit amet, consectetur adipiscing elit. Ut elit tellus, luctus nec ullamcorper mattis, pulvinar dapibus leo.Lorem ipsum dolor sit amet, consectetur adipiscing elit. Ut elit tellus, luctus nec ullamcorper mattis, pulvinar dapibus leo. Lorem ipsum dolor sit amet, consectetur adipiscing elit. Ut elit tellus, luctus nec ullamcorper mattis, pulvinar dapibus leo.

For all topics related to the Industry Forum, please contact

Thomas Hausfeld

Location Plan

Linn Woebler
President

Prof. Linn Woelber is a board certified gynecologic oncologist. Since 2012 she has been working as a consultant at the University Medical Center Hamburg-Eppendorf and is head of one of the biggest certified colposcopy unit in Germany. Her research fields are HPV-related diseases with a focus on prophylactic and therapeutic vaccines; her particular interest is however vulvar (pre)cancer where she could add profoundly to the current clinical and basic knowledge with her work. As a member of national and international guideline groups Prof. Woelber has also developed recent guidelines on the management of vulvar cancer.

Päivi Tommola
Past President

Born in Helsinki, Finland 1959
MD, University of Helsinki, 1985
Board certified in Obstetrics and Gynaecology, University of Helsinki, 1998
D.Med.Sci, University of Helsinki, 2017
Current position: Consultant, Aava Medical Centre

I work as a gynaecologist in the Helsinki area at a private private clinic. I graduated as D.Med.Sci in June 2017, my thesis studies I did on vulvodynia. Because of my research background on vulvodynia and vulvovaginal infections, majority of my patients come with vulvovaginal problems as referrals from colleagues. I have also worked in near collaboration with two research groups in Helsinki University and Helsinki University Hospital, focusing on vaginal microbiome and vulvovaginal lichenoid diseases.

Elmar A. Joura
Past past president

Elmar A. Joura, M.D., is associated Professor and gynecological oncologist at the Medical University of Vienna, Austria and head of the clinic for colposcopy and vulvar disease. He worked in Tanzania, and together with Ron Jones at National Womens Hospital in Auckland and wrote his thesis on vulvar disease. Since 2001 Dr. Joura is investigator for HPV vaccine trials. He was president of EUROGIN in 2016 and is past president of the European college for the study of vulvovaginal disease (ECSVD). Dr. Joura has published more than 160 articles in peer- review journals and given more than 1000 lectures worldwide.

 

Fiona Lewis
President elect

Fiona M Lewis MB BCh, MD FRCP
Consultant Dermatologist, St John’s Institute of Dermatology, Guy’s & St Thomas’ Hospital, London

Fiona Lewis trained in Dermatology at the Royal Hallamshire Hospital, Sheffield and completed her MD thesis on clinical and immunological aspects of lichen sclerosus there. She became a Consultant Dermatologist in 1996 and now runs the Vulval Clinic at St John’s Institute of Dermatology which is a busy tertiary service for complex vulval conditions. She is an Honorary Senior Lecturer at King’s College, London and is programme director for the MSc in Clinical Dermatology.

She teaches on all aspects of vulval disease at a local, national and international level, and has authored various textbooks on vulval disease, as well as being active in clinical research. She is President Elect of the European College for the Study of Vulval Disease.

Manon van Seters
Secretary

Manon van Seters | Consultant Gynaecologist
Worcestershire Royal Hospital (WRH), Worcester, UK

Manon works as a Consultant Gynaecologist in Worcester (UK) since 2016. She completed her training in Obstetrics and Gynaecology in Rotterdam, The Netherlands, followed by a subspecialty training in Gynaecological Oncology in the University Medical Centre Groningen.

Manon has special interest in gynae-oncology and premalignant cervical and vulvar disease. In 2008 she completed a thesis on Vulvar Intraepithelial Neoplasia (VIN). She published several papers in renowned medical journals, including a randomized controlled trial on treatment of VIN with topical Imiquimod, published in the NEJM in 2008. She is secretary of the Executive Council of the ECSVD.

Micheline Moyal-Barracco
Treasurer

Micheline Moyal-Barracco, MD
Paris, France

I am a dermatologist specialized in vulvar disease. I have mainly a private practice. I have also worked as a consultant in vulvar disease in different University Hospitals. I currently work in the department of gynecology of the Hôpital Foch in a newly created section devoid to vulvoperineal pain. I was the president of the European College for the Study of Vulval Disease (ECSVD, 2004-2006), of the International Society for the the Study of Vulvovaginal Diseases (ISSVD, 2009-2011) and of the vulval thematic group of the French Society of Dermatology (REV, 2010-2015).

Sophie Berville
Treasurer
Ulrika Heddini
Council member
  • Ulrika Heddini, MD, PhD
    Senior Consultant, Dep of Ob and Gyn, Danderyds Hospital, Sweden.
  • Medical studies and research at the Karolinska Institutet, Stockholm, Sweden
  • Currently living in Zug, Switzerland

  • Specialist in Obstetrics and Gynaecology since 2009,
  • Since 2008 specializing in diagnosis and treatment of vulvo-vaginal diseases, including vulval-, vaginal- and cervical dysplasia.
  • Research focused on etiology and treatment of Provoked Vestibulodynia.
  • PhD thesis 2014 “Provoked Vestibulodynia – Studies on pain genetics and pain co-morbidity”.
  • Previous Secretary of the ECSVD 2016-2023
  • President of the Swedish Vulvar Association since sept -23
  • Council member of the European College for the Study of Vulvovaginal disease, since 2023
  • Member ISSVD


Publications

  • Plesan A, Hedman U, Xu XJ, Wiesenfeld-Hallin Z .Ketamin and dextromethorphan differentially potentiate the antinociceptive effect of morphine in rats. Anesth and Analg 1998;86:825-829.#
  • Ulrika Heddini, Nina Bohm-Starke, Kent W. Nilsson, and Ulrika Johannesson. Provoked Vestibulodynia – medical factors and co-morbidity associated to treatment outcome. J Sex Med 2012;9:1400–1406
  • Ulrika Heddini, Nina Bohm-Starke, Alfhild Grönbladh, Fred Nyberg, Kent W. Nilsson, Ulrika Johannesson. GCH1-polymorphism and pain sensitivity among women with provoked vestibulodynia. Mol Pain 2012; 12:8:68
  • Ulrika Heddini, Ulrika Johannesson, Alfhild Grönbladh, Fred Nyberg, Kent W. Nilsson, Nina Bohm-Starke. A118G polymorphism in the μ-opioid receptor gene and levels of β-endorphin are associated with provoked vestibulodynia and pressure pain sensitivity. Scan J of Pain 2013;5:10-16 Published online; http://dx.doi.org/10.1016/j.sjpain.2013.10.004
  • Ulrika Heddini, Nina Bohm-Starke, Alfhild Grönbladh, Fred Nyberg, Kent W. Nilsson, Ulrika Johannesson. Serotonin receptor gene (5HT-2A) is associated to provoked vestibulodynia and co-morbid symptoms of pain. J Sex Med 2014;11: 3064-3071
  • Thesis: ”Provoked vestibulodynia – Studies on pain genetics and pain hypersensitivity”.
    ISBN 978-91-7549-357-2
  • Philip Haraldson, Hanna Mühlrad, Ulrika Heddini, Kent W. Nilsson, Nina Bohm-Starke. Botulinum Toxin A as a Treatment for Provoked Vestibulodynia: A Randomized Controlled Trial. Obstet Gynecol. 2020 Sep;136(3):524-532
  • Philip Haraldson, Hanna Mühlrad, Ulrika Heddini, Kent W.Nilsson, Nina Bohm-Starke. Botulinum Toxin A for Provoked Vestibulodynia: 12 Months’ Follow-up of a Randomized Controlled Trial. J Sex Med. 2022 Nov;19(11):1670-1679.
Hans Verstraelen
Council member

Hans Verstraelen, MD, MPH, PhD
Professor
Ghent University & University Hospital, Ghent, Belgium

Hans Verstraelen is a Professor at the Faculty of Medicine & Health Science of Ghent University and a Senior Consultant in vulvovaginal disease at Ghent University Hospital. He established the Vulvar Disease Clinic in the lap of the Department of Obstetrics & Gynaecology in 2008, of which he has been in charge since. His research primarily involves the female genital tract microbiome. He has authored/co-authored over 100 Web-of-Science-indexed papers, of which some half on the vaginal microbiome and bacterial vaginosis.

Christina Damsted-Petersen
Council member

Christina Damsted Petersen, trained as a gynecologist and sexologist, is head of the Clinic “Klinik for kvindesygdomme og seksuel sundhed” in Copenhagen

Received her Ph.d in 2009 with the ph.d. title: What predicts diagnosis, pain relief and sexuality in women with vulvodynia? Botox – a new treatment for vulvodynia?
She is particularly interested in vulva – vaginal diseases, vulvodynia, chronic gynecological and sexual pain, general gynecology and urogynaecology.
Has been working in the field of Sexual Medicine following 5 years of employment at the Sexological Clinic in Copenhagen and is a certified counsellor in sexual Medicine.
Current board member of ECSVD and the Danish committee on Gynecological guidelines, former board member of the Scandiavian Society for Sexual Medicine (SSSM), and of the educational committee under the European Society for Sexual Medicine (ESSM).
Has written several papers on chronic sexual pain, vulvodynia and vulva and vaginitis conditions and has contributed with several chapters to the 1st edition of the ESSM Syllabus of Sexual medicine and the Danish book on Sexual Medicine.
Co-founder of the first Danish society for studies in vulvar diseases, DSVL

Jasmine Abdulcadir
Council member

Obstetrician and Gynecologist trained in sexual medicine and vulva disease. Responsible of the ObGyn Emergency Department and the care after sexual assault; founder and responsible of the clinic for women and girls with female genital mutilation/cutting (FGM/C) at Geneva University Hospital, where she also runs a vulva clinic. Assistant Professor at the Faculty of Medicine of the University of Geneva. Previous consultant at WHO, MSF and current consultant at the Swiss Network against female circumcision and Swiss State Secretary of migration. Author of more than 70 peer reviewed papers and chapters. For her work in improving the health of women and girls with FGM/C, she was awarded a Knighthood by the Italian Republic.

Pia Halonen
Council member

“Pia Halonen is a gynecologist working at the Helsinki University Hospital in Finland. She completed her medical degree, obgyn specialist, and PhD at the University of Helsinki. She treats patients with vulvovaginal complaints at the vulvar clinic and HPV-related problems at the colposcopy unit. Her PhD thesis focused on the epidemiology of lichen sclerosus and lichen planus. The goal of ongoing research is the improvement of care for patients suffering from vulvar diseases.”